株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心膜炎:世界の治験動向

Pericarditis Global Clinical Trials Review, H1, 2018

発行 GlobalData 商品コード 314742
出版日 ページ情報 英文 31 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.57円で換算しております。
Back to Top
心膜炎:世界の治験動向 Pericarditis Global Clinical Trials Review, H1, 2018
出版日: 2018年04月30日 ページ情報: 英文 31 Pages
概要

当レポートでは、心膜炎治療薬に関する治験の最新動向について分析しており、G7 (主要7カ国) 諸国における段階別および進捗状況別の治験件数、被験者数、有望なスポンサー、治験に携わっている主な企業や機関、有望な薬剤の情報をまとめています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数

G7諸国での治験件数:心血管疾患治療薬の治験における心膜炎の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験プロファイルの概要

付録

目次
Product Code: GDHC4954CTIDB

GlobalData's clinical trial report, "Pericarditis Global Clinical Trials Review, H1, 2018" provides an overview of Pericarditis clinical trials scenario. This report provides top line data relating to the clinical trials on Pericarditis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Europe 9
  • Top Countries Contributing to Clinical Trials in North America 10
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 11
  • Clinical Trials by G7 Countries: Proportion of Pericarditis to Cardiovascular Clinical Trials 12
  • Clinical Trials by Phase in G7 Countries 13
  • Clinical Trials in G7 Countries by Trial Status 14
  • Clinical Trials by Phase 15
  • Clinical Trials by Trial Status 16
  • Clinical Trials by End Point Status 17
  • Clinical Trials by Sponsor Type 18
  • Prominent Sponsors 19
  • Top Companies Participating in Pericarditis Therapeutics Clinical Trials 20
  • Prominent Drugs 21
  • Clinical Trial Profile Snapshots 22

Appendix 29

  • Abbreviations 29
  • Definitions 29
  • Research Methodology 30
  • Secondary Research 30
  • About GlobalData 31
  • Contact Us 31
  • Source 31

List of Tables

List of Tables

  • Pericarditis Therapeutics, Global, Clinical Trials by Region, 2018* 6
  • Pericarditis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
  • Pericarditis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
  • Pericarditis Therapeutics Clinical Trials, Europe, Top Countries, 2018* 9
  • Pericarditis Therapeutics Clinical Trials, North America, Top Countries, 2018* 10
  • Pericarditis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 11
  • Proportion of Pericarditis to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 12
  • Pericarditis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
  • Pericarditis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
  • Pericarditis Therapeutics, Global, Clinical Trials by Phase, 2018* 15
  • Pericarditis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 16
  • Pericarditis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 17
  • Pericarditis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 18
  • Pericarditis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 19
  • Pericarditis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 20
  • Pericarditis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 21

List of Figures

List of Figures

  • Pericarditis Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
  • Pericarditis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
  • Pericarditis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
  • Pericarditis Therapeutics Clinical Trials, Europe, Top Countries (%), 2018* 9
  • Pericarditis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 11
  • Proportion of Pericarditis to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 12
  • Pericarditis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 13
  • Pericarditis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 14
  • Pericarditis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 15
  • Pericarditis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 16
  • Pericarditis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 17
  • Pericarditis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 18
  • Pericarditis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 19
  • Pericarditis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 20
  • Pericarditis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 21
  • GlobalData Methodology 30
Back to Top